# Bepotastine Besilate

NDC: 70069-711
Generic name: Bepotastine Besilate
Labeler / Manufacturer: Somerset Therapeutics, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SOLUTION
Routes: OPHTHALMIC
Marketing started: 20241010

FDA application: ANDA217770

## Active ingredients

- BEPOTASTINE BESILATE: 15 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70069-711"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70069-711
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd6a061d-8ad7-4ad1-b039-1e3aa3435d32